Texas to invest in drug delivery company

> Texas is going to invest $9.2 million from its Texas Emerging Technology Fund into three companies spun out of InCube Labs. Among them is Fe3 Medical, which will get $2.8 million to commercialize drug delivery technology that enables the safe, non-toxic transport of about 10 mg of iron across the skin for sufferers of iron-deficiency anemia. Report

> pSivida, a Watertown, Mass.-based ophthalmic drug-delivery device maker, saw a 388 percent increase in revenues during the fourth quarter of fiscal 2010. Report | But you read it here first

> Writing in the journal Nanobiotechnology, researchers say they have developed a novel drug delivery system to provide sustained delivery of CF "correctors" and "anti-inflammatories" to the lungs, demonstrating a promising treatment for cystic fibrosis. Abstract

> Johns Hopkins University researchers have developed tiny drug-delivery tools that could be introduced into the human body and can change shape on command--clamping shut or popping open in response to specific chemical cues. Report
> Drug delivery patent application of the week: Medical Devices Having Nanoporous Coatings for Controlled Therapeutic Agent Delivery Patent Application. Patent application
> Drug delivery science abstract of the week: Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. Abstract

> Drug delivery tweet of the week: DrugDelivery helps save lives. Do you want that success on your conscience? New Product Engineer. Posting | Tweet

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.